Kirsten E. Smith

705 total citations
38 papers, 410 citations indexed

About

Kirsten E. Smith is a scholar working on Pharmacology, Biochemistry and Organic Chemistry. According to data from OpenAlex, Kirsten E. Smith has authored 38 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pharmacology, 19 papers in Biochemistry and 14 papers in Organic Chemistry. Recurrent topics in Kirsten E. Smith's work include Alkaloids: synthesis and pharmacology (24 papers), Traditional and Medicinal Uses of Annonaceae (19 papers) and Chemical synthesis and alkaloids (14 papers). Kirsten E. Smith is often cited by papers focused on Alkaloids: synthesis and pharmacology (24 papers), Traditional and Medicinal Uses of Annonaceae (19 papers) and Chemical synthesis and alkaloids (14 papers). Kirsten E. Smith collaborates with scholars based in United States, Malaysia and United Kingdom. Kirsten E. Smith's co-authors include Oliver Grundmann, Jeffrey M. Rogers, David H. Epstein, Albert Garcia‐Romeu, Marc T. Swogger, Justin C. Strickland, Kelly E. Dunn, Christopher R. McCurdy, Jack E. Henningfield and Charles A. Veltri and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neuroscience & Biobehavioral Reviews.

In The Last Decade

Kirsten E. Smith

35 papers receiving 405 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kirsten E. Smith United States	12	296	238	181	67	45	38	410
Jeffrey M. Rogers United States	13	318 1.1×	249 1.0×	195 1.1×	80 1.2×	21 0.5×	33	552
Joshua C. Black United States	11	103 0.3×	72 0.3×	76 0.4×	75 1.1×	65 1.4×	46	356
Máté Kapitány‐Fövény Hungary	13	159 0.5×	137 0.6×	88 0.5×	103 1.5×	155 3.4×	37	579
Marion A. Coe United States	7	115 0.4×	95 0.4×	74 0.4×	63 0.9×	35 0.8×	12	393
Pierluigi Simonato Italy	11	173 0.6×	140 0.6×	93 0.5×	91 1.4×	331 7.4×	17	665
Nurul Iman Ismail Malaysia	5	331 1.1×	277 1.2×	162 0.9×	81 1.2×	19 0.4×	8	391
Hugh Claridge United Kingdom	13	74 0.3×	58 0.2×	46 0.3×	92 1.4×	127 2.8×	20	457
Christine Goodair United Kingdom	10	74 0.3×	58 0.2×	46 0.3×	73 1.1×	116 2.6×	23	388
Duccio Papanti United Kingdom	16	96 0.3×	61 0.3×	56 0.3×	266 4.0×	306 6.8×	26	724
Flaminia Pantano Italy	12	87 0.3×	24 0.1×	54 0.3×	112 1.7×	202 4.5×	15	511

Countries citing papers authored by Kirsten E. Smith

Since Specialization

Citations

This map shows the geographic impact of Kirsten E. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirsten E. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirsten E. Smith more than expected).

Fields of papers citing papers by Kirsten E. Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kirsten E. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirsten E. Smith. The network helps show where Kirsten E. Smith may publish in the future.

Co-authorship network of co-authors of Kirsten E. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Kirsten E. Smith. A scholar is included among the top collaborators of Kirsten E. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kirsten E. Smith. Kirsten E. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Smith, Kirsten E., Raju S. Kanumuri, Abhisheak Sharma, et al.. (2025). Complicating Factors Surrounding Concurrent Use of Kratom and a Novel 7-hydroxymitragynine Product Among a Participant Enrolled in a Kratom Clinical Trial. Journal of Addiction Medicine.

Boyer, Edward W., et al.. (2025). Substance Use Disorder Following Consumption of a Novel Synthetic 7-Hydroxymitragynine Product. Journal of Addiction Medicine.

Smith, Kirsten E., et al.. (2025). Kratom use among ethnobotanical tea bar patrons in Colorado: Subjective drug effects, adverse reactions, and perceived benefits of use. Drug and Alcohol Dependence Reports. 16. 100361–100361.

Hill, Katherine A., Edward W. Boyer, Oliver Grundmann, & Kirsten E. Smith. (2025). De facto opioids: Characterization of novel 7-hydroxymitragynine and mitragynine pseudoindoxyl product marketing. Drug and Alcohol Dependence. 272. 112701–112701. 10 indexed citations

Smith, Kirsten E., et al.. (2025). Systematic Review of Clinical Case Reports Involving Tianeptine Products: “Gas Station Heroin” Hype or Fact?. Current Addiction Reports. 12(1). 1 indexed citations

Smith, Kirsten E., Leigh V. Panlilio, Abhisheak Sharma, et al.. (2024). Time course of kratom effects via ecological momentary assessment, by product type, dose amount, and assayed alkaloid content. Drug and Alcohol Dependence. 264. 112460–112460. 4 indexed citations

Bergeria, Cecilia L., Cassandra D. Gipson, Kirsten E. Smith, William W. Stoops, & Justin C. Strickland. (2024). Opioid craving does not incubate over time in inpatient or outpatient treatment studies: Is the preclinical incubation of craving model lost in translation?. Neuroscience & Biobehavioral Reviews. 160. 105618–105618. 9 indexed citations

Mun, Chung Jung, Leigh V. Panlilio, Kelly E. Dunn, et al.. (2024). Kratom (Mitragyna speciosa) use for self-management of pain: Insights from cross-sectional and ecological momentary assessment data. Journal of Pain. 26. 104726–104726. 2 indexed citations

Hill, Katherine, et al.. (2024). Use of Cannabinoids by People Who Consume Kratom in the United States. Journal of Addiction Medicine. 18(6). 719–722. 2 indexed citations

10.

Smith, Kirsten E., Leigh V. Panlilio, Oliver Grundmann, et al.. (2024). Ecological Momentary Assessment of Self-Reported Kratom Use, Effects, and Motivations Among US Adults. JAMA Network Open. 7(1). e2353401–e2353401. 19 indexed citations

11.

Hill, Katherine, et al.. (2023). Evaluating health information provided to kratom consumers by good manufacturing practice-qualified vendors. Substance Abuse Treatment Prevention and Policy. 18(1). 21–21. 8 indexed citations

12.

Henningfield, Jack E., Marek C. Chawarski, Albert Garcia‐Romeu, et al.. (2023). Kratom withdrawal: Discussions and conclusions of a scientific expert forum. SHILAP Revista de lepidopterología. 7. 100142–100142. 7 indexed citations

13.

Smith, Kirsten E., Kelly E. Dunn, Christopher R. McCurdy, et al.. (2023). Novel methods for the remote investigation of emerging substances: Application to kratom.. Experimental and Clinical Psychopharmacology. 32(2). 215–227. 12 indexed citations

14.

Smith, Kirsten E., et al.. (2023). Kratom’s Emergence and Persistence Within the US Polydrug Epidemic. Current Addiction Reports. 10(2). 262–271. 10 indexed citations

15.

Bertz, Jeremiah W., Leigh V. Panlilio, Kirsten E. Smith, et al.. (2022). Being at work improves stress, craving, and mood for people with opioid use disorder: Ecological momentary assessment during a randomized trial of experimental employment in a contingency-management-based therapeutic workplace. Behaviour Research and Therapy. 152. 104071–104071. 9 indexed citations

16.

Smith, Kirsten E., et al.. (2022). Nonfatal opioid overdoses before and after Covid-19: Regional variation in rates of change. PLoS ONE. 17(3). e0263893–e0263893. 11 indexed citations

17.

Pope, Natalie D., Paula K. Baldwin, Allison Gibson, & Kirsten E. Smith. (2022). Becoming a Caregiver: Experiences of Young Adults Moving into Family Caregiving Roles. Journal of Adult Development. 29(2). 147–158. 16 indexed citations

18.

Smith, Kirsten E.. (2022). Disease and decision. Journal of Substance Abuse Treatment. 142. 108874–108874. 15 indexed citations

19.

Singh, Darshan, Suresh Narayanan, Balasingam Vicknasingam, et al.. (2021). The Use of Kratom (Mitragyna speciosa Korth.) Among People Who Co-use Heroin and Methamphetamine in Malaysia. Journal of Addiction Medicine. 16(2). 223–228. 23 indexed citations

20.

Bertz, Jeremiah W., Kirsten E. Smith, Leigh V. Panlilio, et al.. (2021). Quality of life during a randomized trial of a therapeutic-workplace intervention for opioid use disorder: Web-based mobile assessments reveal effects of drug abstinence and access to paid work. SHILAP Revista de lepidopterología. 1. 100011–100011. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact